BeOne Medicines Ltd. (ONC)
379.13
+7.15
(+1.92%)
USD |
NASDAQ |
Aug 25, 12:46
BeOne Medicines Debt to Equity Ratio : 0.3961 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3961 |
| March 31, 2026 | 0.4313 |
| December 31, 2025 | 0.4585 |
| September 30, 2025 | 0.4613 |
| June 30, 2025 | 0.272 |
| March 31, 2025 | 0.2848 |
| December 31, 2024 | 0.3241 |
| September 30, 2024 | 0.3206 |
| June 30, 2024 | 0.3238 |
| March 31, 2024 | 0.3164 |
| December 31, 2023 | 0.263 |
| September 30, 2023 | 0.1541 |
| June 30, 2023 | 0.1784 |
| March 31, 2023 | 0.1311 |
| December 31, 2022 | 0.1361 |
| September 30, 2022 | 0.1526 |
| June 30, 2022 | 0.1193 |
| March 31, 2022 | 0.1142 |
| December 31, 2021 | 0.1133 |
| September 30, 2021 | 0.2084 |
| June 30, 2021 | 0.1886 |
| March 31, 2021 | 0.1595 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.1452 |
| September 30, 2020 | 0.0568 |
| June 30, 2020 | 0.1426 |
| March 31, 2020 | 0.106 |
| December 31, 2019 | 0.2882 |
| September 30, 2019 | 0.2231 |
| June 30, 2019 | 0.1772 |
| March 31, 2019 | 0.1682 |
| December 31, 2018 | 0.1141 |
| September 30, 2018 | 0.0995 |
| June 30, 2018 | 0.1729 |
| March 31, 2018 | 0.1292 |
| December 31, 2017 | 0.2459 |
| September 30, 2017 | 0.2111 |
| June 30, 2017 | 0.5972 |
| March 31, 2017 | 0.0645 |
| December 31, 2016 | 0.049 |
| September 30, 2016 | 0.096 |
| June 30, 2016 | 0.048 |
| March 31, 2016 | 0.0256 |
| December 31, 2015 | 0.2797 |
| September 30, 2015 | 0.2061 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CRISPR Therapeutics AG | 0.4487 |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| AC Immune SA | 0.1166 |
| Idorsia Ltd. | -1.124 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.176B |
| Total Liabilities (Quarterly) | 3.973B |
| Shareholders Equity (Quarterly) | 5.174B |
| Current Ratio | 3.405 |
| Net Debt Paydown Yield | -0.71% |